In conjunction with the American Society of Retina Specialists, the Macula Society, the Retina Society and Club Jules Gonin
Date and Time:
Friday, Nov. 15
Saturday, Nov. 16
Location: Morial Convention Center
- 2013 Retina Subspecialty Day Schedule will be available soon
- Online Program Search for Subspecialty Day courses and events will be available in June.
Registration and Hotel Reservations
Registration for the Retina Subspecialty meeting allows you to:
- Visit the Annual Meeting Exhibit Hall on Saturday, Nov. 16.
- Experience other Subspecialty Day meetings held on Friday, Nov. 15 – Refractive Surgery.
- Float among all Subspecialty Day meetings held on Saturday, Nov. 16 – Cornea, Glaucoma, Neuro-Ophthalmology, Oculofacial Plastic Surgery, Pediatric Ophthalmology, Refractive Surgery and Retina.
Tarek S. Hassan, MD; Peter K. Kaiser, MD
Program Planning Group
Pravin U. Dugel, MD; Tarek S. Hassan, MD; Peter K. Kaiser, MD; Jennifer I. Lim, MD
The 2013 Retina Subspecialty Day aims to provide a comprehensive and focused medical and surgical retina update for the retina subspecialist, interested ophthalmologist, and ophthalmologist in training. The meeting focuses on up-to-date, clinically and scientifically relevant retina topics presented by an international group of respected retina specialists. The major educational goals are to highlight new clinical and investigative information and to transfer it to the participant so that it is useful for patient care. The meeting attains these goals by engaging the participant in didactic presentations, panel discussions, audience response polling, and audience response question generation for moderated panels, as well as in numerous informal "breaks with the experts."
The intended target audience for this program is vitreoretinal specialists, members in fellowship training and general ophthalmologists who are engaged in the diagnosis and treatment of vitreoretinal diseases.
The goals of this program are to:
- Provide attendees with a comprehensive, state-of-the-art update on the diagnosis and management of vitreoretinal diseases.
- Provide insight into new and upcoming therapeutic options for the treatment of a variety of disorders.
Upon completion of this activity, participants should be able to:
- Explain the current management of macular edema secondary to retinal occlusive disease and diabetic retinopathy.
- Explain the pathobiology and management of atrophic and exudative AMD and other causes of CNV.
- Identify emerging developments in retinal imaging.
- Describe new vitreoretinal surgical techniques and instrumentation.
- Identify new developments in hereditary retinal degenerations, pediatric retinal diseases and ocular oncology.
- Summarize current and new clinical trial data for retinal diseases such as AMD, diabetic retinopathy, and retinal vein occlusion
The American Academy of Ophthalmology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The American Academy of Ophthalmology designates this live activity for a maximum of 14 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Attendees registered as exhibitors, spouses and guests are not eligible for CME credits.